Nascent Biotech Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2015 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Nascent Biotech Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q4 2022.
  • Nascent Biotech Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2022 was 120M shares, a 6.36% increase year-over-year.
  • Nascent Biotech Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2017 was 25.9M shares, a 9.31% increase from 2016.
  • Nascent Biotech Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2016 was 23.7M shares, a 20% increase from 2015.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 120M +7.14M +6.36% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q4 2021 112M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q1 2018 25.9M +2.21M +9.31% Jan 1, 2018 Mar 31, 2018 10-K 2018-06-29
Q4 2017 27.2M +5.3M +24.2% Oct 1, 2017 Dec 31, 2017 10-Q 2018-01-31
Q3 2017 24M +1.96M +8.85% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q2 2017 23.8M +1.61M +7.25% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 23.7M Jan 1, 2017 Mar 31, 2017 10-K 2018-06-29
Q4 2016 21.9M +785K +3.73% Oct 1, 2016 Dec 31, 2016 10-Q 2018-01-31
Q3 2016 22.1M +3.79M +20.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 22.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q4 2015 21.1M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 18.3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.